Español
Questions About Cancer? 1-800-4-CANCER
  • Email

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 44 for your search:
Drug:  human papillomavirus 16/18 L1 virus-like particle/AS04 vaccine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 13 to 15 at first immunization
Sponsor: Other
Protocol IDs: HPV CSP01, NCT00956553

2.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 to 25
Sponsor: Pharmaceutical / Industry
Protocol IDs: CDR0000441189, NCI-04-C-N191, NCI-590299/009, GSK-590299/009, NCT00128661

3.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 to 25
Sponsor: Pharmaceutical / Industry
Protocol IDs: 104772, NCT00250276

4.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 26 and older
Sponsor: Pharmaceutical / Industry
Protocol IDs: 104820, NCT00294047

5.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 to 35
Sponsor: Pharmaceutical / Industry
Protocol IDs: 106001, NCT00306241

6.

Phase: Phase III
Type: Natural history/Epidemiology, Prevention
Status: Completed
Age: 10 to 25
Sponsor: Pharmaceutical / Industry
Protocol IDs: 107476 (M18), 107477, 107479, 107481, NCT00337818

7.

Phase: Phase III
Type: Prevention
Status: Completed
Age: 18 to 35
Sponsor: Pharmaceutical / Industry
Protocol IDs: 104479, NCT00344032

8.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 to 35
Sponsor: Pharmaceutical / Industry
Protocol IDs: 105926, NCT00345878

9.

Phase: Phase III
Type: Natural history/Epidemiology, Prevention
Status: Completed
Age: 10 to 14
Sponsor: Pharmaceutical / Industry
Protocol IDs: 104896 (month 18 FU), 104902, 104904, 104918, NCT00316706

10.

Phase: Phase III
Type: Natural history/Epidemiology, Prevention
Status: Completed
Age: 11 to 18
Sponsor: Pharmaceutical / Industry
Protocol IDs: 107682, NCT00369824

11.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 to 45
Sponsor: Pharmaceutical / Industry
Protocol IDs: 108933, NCT00423046

12.

Phase: Phase III
Type: Prevention
Status: Completed
Age: 10 to 18
Sponsor: Pharmaceutical / Industry
Protocol IDs: 108464, NCT00426361

13.

Phase: Phase III
Type: Prevention
Status: Completed
Age: 26 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 109801, NCT00456807

14.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 10 to 25
Sponsor: Pharmaceutical / Industry
Protocol IDs: 106069, NCT00481767

15.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 15 to 25
Sponsor: Pharmaceutical / Industry
Protocol IDs: 107291, NCT00485732

16.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 10 to 15
Sponsor: Pharmaceutical / Industry
Protocol IDs: 110168, NCT00492544

17.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 15 to 25
Sponsor: Pharmaceutical / Industry
Protocol IDs: 109179, NCT00552279

18.

Phase: Phase III
Type: Natural history/Epidemiology, Prevention
Status: Completed
Age: 9 to 15
Sponsor: Pharmaceutical / Industry
Protocol IDs: 110886, NCT00578227

19.

Phase: Phase III
Type: Prevention
Status: Completed
Age: 20 to 25
Sponsor: Pharmaceutical / Industry
Protocol IDs: 111567, NCT00637195

20.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 9 to 15
Sponsor: Pharmaceutical / Industry
Protocol IDs: 111507, NCT00652938

21.

Phase: Phase III
Type: Prevention
Status: Completed
Age: 15 to 55
Sponsor: Pharmaceutical / Industry
Protocol IDs: 103514, 105879, 105880, 105881, 105882, NCT00196937

22.

Phase: Phase III
Type: Prevention
Status: Closed
Age: 18 to 25
Sponsor: Pharmaceutical / Industry
Protocol IDs: 107638, NCT00779766

23.

Phase: Phase III
Type: Prevention
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 111955, NCT00799825

24.

Phase: Phase III
Type: Prevention
Status: Completed
Age: 25 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 111712, NCT00811798

25.

Phase: Phase III
Type: Prevention
Status: Completed
Age: 26 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 111758, NCT00849381
1   
New Search